RT @PopovianPharmD: Garbage in, garbage out, drug list prices, useless when debating drug costs, need net spending on drugs wsj.com/articles/drugm… via @WSJ
RT @emmarcourt: Ye gods. Mylan’s EpiPen Profit 60%…
posted on September 26, 2016 by
RT @emmarcourt: Ye gods. Mylan’s EpiPen Profit 60% Higher Than Told to Congress on.wsj.com/2dmdB5j via @WSJ
RT @LauraLandroWSJ: Doctors, hospitals create ever…
posted on September 26, 2016 by
RT @LauraLandroWSJ: Doctors, hospitals create ever more complex algorithms to forecast patients’ medical future @melaevans t on.wsj.com/2cOvSTp via @WSJ
RT @ScottGottliebMD: My op ed in tomorrow’s @WSJ e…
posted on September 14, 2016 by
RT @ScottGottliebMD: My op ed in tomorrow’s @WSJ edit page on path to single payer: Clinton’s stealthy single-payer gambit wsj.com/articles/clint… @WSJopinion
RT @annawmathews: Discussion of Aetna’s ACA pullba…
posted on August 17, 2016 by
RT @annawmathews: Discussion of Aetna’s ACA pullback is part of broader debate over cause/cure for insurers’ exchange losses on.wsj.com/2bxY6Ts via @WSJ
RT @annawmathews: The economics of what’s not work…
posted on August 17, 2016 by
RT @annawmathews: The economics of what’s not working in the ACA: a fascinating column from Greg Ip on.wsj.com/2byDL0s via @WSJ @greg_ip
RT @accountablecare: More nonprofit hospitals are…
posted on May 31, 2016 by
RT @accountablecare: More nonprofit hospitals are becoming more transparent to attract investors on.wsj.com/1TnvbSB via @WSJ
RT @mjkeegan1127: Price freeze complicates Oregon…
posted on November 22, 2013 by
RT @mjkeegan1127: Price freeze complicates Oregon insurance extension; insurers have until today to decide on.wsj.com/18rvfJP via @WSJ
RT @charlesornstein: Caution: this could be bad if…
posted on November 5, 2013 by
RT @charlesornstein: Caution: this could be bad if it holds. Young Avoid New Health Coverage, via @WSJ on.wsj.com/HDhSwd
